[
  {
    "ts": null,
    "headline": "Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price?",
    "summary": "If you are wondering whether West Pharmaceutical Services at around US$254 per share is offering fair value or stretching expectations, you are not alone. The stock has recently shown mixed performance, with a 5.5% gain over the past 7 days and 7.8% over 30 days, but a year to date return of an 8.0% decline and a 22.1% decline over 3 years. Over the last 12 months the share price return sits at 9.9%, while the 5 year return is a 1.8% decline. Together, these figures suggest a story that is...",
    "url": "https://finnhub.io/api/news?id=9690b0a13af8e100e8d1c711cd503ddd4bbec1e0a430e0b35b31d93609cf4fb5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772302588,
      "headline": "Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price?",
      "id": 139265905,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "If you are wondering whether West Pharmaceutical Services at around US$254 per share is offering fair value or stretching expectations, you are not alone. The stock has recently shown mixed performance, with a 5.5% gain over the past 7 days and 7.8% over 30 days, but a year to date return of an 8.0% decline and a 22.1% decline over 3 years. Over the last 12 months the share price return sits at 9.9%, while the 5 year return is a 1.8% decline. Together, these figures suggest a story that is...",
      "url": "https://finnhub.io/api/news?id=9690b0a13af8e100e8d1c711cd503ddd4bbec1e0a430e0b35b31d93609cf4fb5"
    }
  },
  {
    "ts": null,
    "headline": "Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase",
    "summary": "In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 per share, payable on May 6, 2026 to shareholders of record on April 29, 2026. This renewed commitment to buybacks and dividends, following full use of the prior repurchase program, highlights how management is currently prioritizing returning excess cash to shareholders. With this sizable new...",
    "url": "https://finnhub.io/api/news?id=cfaa83f5e75fe91119199eb9aaa77b7944c466efdacf675d84fe3dc79c1476a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772280716,
      "headline": "Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase",
      "id": 139263106,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 per share, payable on May 6, 2026 to shareholders of record on April 29, 2026. This renewed commitment to buybacks and dividends, following full use of the prior repurchase program, highlights how management is currently prioritizing returning excess cash to shareholders. With this sizable new...",
      "url": "https://finnhub.io/api/news?id=cfaa83f5e75fe91119199eb9aaa77b7944c466efdacf675d84fe3dc79c1476a8"
    }
  }
]